作者：侯双双1，张革红2，陈路锋1，马娟1，李险峰1

单位：1.山西医科大学第一医院/山西医科大学第一临床医学院 放疗科，山西 太原 030001；2.山西医科大学第一医院 肿瘤综合科，山西 太原 030001

Authors: Hou Shuangshuang1, Zhang Gehong2, Chen Lufeng1, Ma Juan1, Li Xianfeng1

Unit:  1.Radiation Oncology Department, First Hospital of Shanxi Medical University / First Clinical Medical College of Shanxi Medical University, Taiyuan 030001, Shanxi, China；2.General Oncology Department, First Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, China

摘要：

近年来，肿瘤相关的全身炎症反应被证实与疾病的进展有关，血清中炎性标志物在结直肠癌患者疗效预测方面的价值已被广泛研究。另外，随着对肿瘤患者因各种原因出现不同程度的营养风险进而加速疾病进展的认识，也有越来越多的研究探索炎性-营养标志物在肿瘤患者中的预后评估价值。本文就国内外基于白蛋白的炎性-营养标志物在结直肠癌患者术后并发症、复发和预后评估方面的研究进展作一综述。

关键词： 结直肠癌；白蛋白；基于白蛋白的炎性-营养标志物；预后

Abstract：

Recently, tumor-related systemic inflammatory reaction is proved to be associated with disease progression, and serum inflammatory markers have been extensively studied in predictive value of the efficacy in patients with colorectal cancer. Besides, with the knowledge that patients with cancer have different levels of nutritional risk due to various reasons and thus accelerate disease progression, a lot of studies have been conducted to explore the prognostic value of inflammatory-nutritional markers in cancer patients. Therefore, this article reviews the progress of albumin-based inflammatory-nutritional markers in evaluating postoperative complications, recurrence and prognosis in patients with colorectal cancer.

Key Words:  Colorectal cancer; Albumin; Albumin -based inflammatory -nutritional markers; Prognosis

注：网络优先发布